Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

3 thoradh

  1. SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product

    #572602

    IATE #3502882
    frithghníomh díobhálach amhrasta Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    mutmaßliche Nebenwirkung
    de
    suspected adverse reaction | SAR
    en
    Sainmhíniú adverse reaction in respect of which there is at least a reasonable possibility of there being a causal relationship between a medicinal product and the event Tagairt COM-Terminology Coordination, based on: Directive 2010/84/EU amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use
    Nóta See also: adverse reaction
    effet indésirable présumé
    fr
    Sainmhíniú effet indésirable pour lequel un lien de causalité entre l’événement et le médicament ne peut être exclu Tagairt COM-Document interne: ENTR/2008/80076/02/02
  2. PRODUCTION, TECHNOLOGY AND RESEARCH|research and intellectual property|research|scientific research · SOCIAL QUESTIONS|health|pharmaceutical industry

    #599894

    IATE #3623652
    scagthástáil a dhéanamh ar fhrithghníomhartha díobhálacha tromchúiseacha neamhthuartha amhrasta Tagairt Rialachán Cur Chun Feidhme (AE) 2022/20 lena leagtar síos rialacha maidir le cur i bhfeidhm Rialachán (AE) Uimh. 536/2014 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le bunú na rialacha agus na nósanna imeachta um chomhar idir na Ballstáit sa mheasúnú sábháilteachta ar thrialacha cliniciúla, CELEX:32022R0020/GA Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Sainmhíniú frithghníomhartha díobhálacha tromchúiseacha neamhthuartha amhrasta a shainaithint go córasach, ar frithghníomhartha iad lena gceanglaítear measúnú as a dtiocfaidh cinneadh maidir leis an ngá atá le fógra a thabhairt do na Ballstáit tuairiscithe agus do na Ballstáit lena mbaineann Tagairt Rialachán Cur Chun Feidhme (AE) 2022/20 lena leagtar síos rialacha maidir le cur i bhfeidhm Rialachán (AE) Uimh. 536/2014 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le bunú na rialacha agus na nósanna imeachta um chomhar idir na Ballstáit sa mheasúnú sábháilteachta ar thrialacha cliniciúla, CELEX:32022R0020/GA
    Überprüfung von mutmaßlichen unerwarteten schwerwiegenden Nebenwirkungen
    de
    Sainmhíniú systematische Feststellung von mutmaßlichen unerwarteten schwerwiegenden Nebenwirkungen, die eine Bewertung und anschließende Entscheidung darüber erfordern, ob eine Unterrichtung der berichterstattenden Mitgliedstaaten sowie der betroffenen Mitgliedstaaten erforderlich ist Tagairt COM-internes Dokument: SANTE-2021-81060 (klinische Prüfungen)
    screening of suspected unexpected serious adverse reactions
    en
    Sainmhíniú systematic identification of suspected unexpected serious adverse reactions that require an assessment leading to a decision on the need to notify the reporting Member States and Member States concerned Tagairt Commission Implementing Regulation (EU) 2022/20 laying down rules for the application of Regulation (EU) No 536/2014 as regards setting up the rules and procedures for the cooperation of the Member States in safety assessment of clinical trials
  3. SOCIAL QUESTIONS|health|pharmaceutical industry

    #569855

    IATE #2222817
    frithghníomh trom díobhálach amhrasta neamhthuartha Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    mutmaßliche unerwartete schwerwiegende Nebenwirkung
    de
    suspected unexpected serious adverse reaction | serious suspected unexpected adverse drug reaction | SUSAR | suspected serious unexpected adverse drug reaction
    en
    Sainmhíniú suspected adverse reaction related to an investigational medicinal product which occurs in the course of a clinical trial, and which is both unexpected and serious Tagairt COM-EN, based on:Voisin Consulting Life Sciences (VCLS) > resources > glossary > suspected unexpected serious adverse reaction (SUSAR) (9.3.2022)
    Nóta Reports of these reactions are subject to expedited submission to health authorities.
    suspicions d'effets indésirables graves inattendus | SUSAR
    fr